The vitreous (also called the vitreous body, vitreous humor, or corpus vitreum) is a transparent, gelatinous substance that fills the posterior segment of the eyeball — the space between the crystalline lens anteriorly and the retina posteriorly. It comprises approximately 80% of the eye’s total volume and is composed primarily of water (~99%), along with hyaluronic acid, collagen fibrils (type II), and scattered hyalocytes (phagocytic cells). The vitreous serves to maintain the spherical shape of the eye, support the retina against the posterior wall, and allow undistorted transmission of light to the macula. Unlike aqueous humor, vitreous is not continuously replenished — it is largely acellular and avascular. With aging, the gel undergoes liquefaction (synchysis) and collapse (syneresis), often leading to posterior vitreous detachment (PVD), floaters, or, in complicated cases, traction on the retina. During vitrectomy, the vitreous is replaced with saline, gas bubbles, or silicone oil.
latin
From Latin vitreus (“of glass,” “glassy”), derived from vitrum (“glass”). The adjective describes the substance’s hallmark transparency and glass-like clarity, as observed by early anatomists during dissection. The companion word humor (Latin: umor, “fluid, moisture”) reflects the historical four-humors theory of medicine. Together, vitreous humor = “glassy fluid.” The adjective form vitreous was first used in English in the 14th century; the noun form referring to the eye structure dates to 1869 (Merriam-Webster). The prefix vitre-/vitro- appears in related terms such as vitreoretinal and vitritis.
Vitrectomy, mechanical, pars plana; with removal of subretinal membrane (e.g., AMD)
Key Coding Tips
67025 (vitreous substitute) is a major surgery with a 90-day global period; 67028 (pharmacologic agent) is a minor procedure with zero global days.
67015 is bundled with 67028 per NCCI edits — do not report together for the same eye; report 67015 alone (higher RVU).
For intravitreal injections, laterality modifiers are critical: -RT (right eye), -LT (left eye), -50 (bilateral — payer-dependent).
Additional modifiers: -59 or -XE to distinguish separately payable procedures; -78 for return to OR during global; -79 for unrelated procedure during global; -JW for discarded drug waste.
For bilateral vitrectomy, confirm payer rules — some require two separate line items with -RT/-LT rather than modifier -50.